UW Medicine breaks down the peptide therapies now showing up everywhere and what they are.
Recap by typeshit. Full story at Right as Rain by UW Medicine.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Dissolving peptide films are spreading in biohacking circles. The piece sorts out what's approved, what's being sold and what the science supports.
A preprint using health records found BPC-157 users rose from about 54 in early 2022 to 1,018 in early 2026, and most waited two months to tell a doctor.
Loading…